Long-term remission of advanced liver cancer in 46% of patients achieved with combination therapy

Published Date: 26 May 2025

An interdisciplinary research team has demonstrated a durable and lasting response to a novel treatment—combined locoregional therapy and immunotherapy (LRT-IO)—for advanced liver cancer patients. The study marks the ...

Read Full News

Latest News

Branded Bevacizumab: Retina Breakthrough or Bankbuster?

Bevacizumab is a cornerstone retina drug that has been used off-label for decades. Where the FDA-cleared branded version fits in may be a matter of cost and acceptance.

Worker Violence, Staff Shortages Spark Hospital Strikes

Healthcare workers are facing more violence and staff shortages, fueling hospital strikes as workers push for safer workplaces and enough staff to care for patients.

Retinal Thinning Predicts Cognitive Decline in MS

Thinning of specific retinal layers predicts cognitive worsening in patients with multiple sclerosis, even without disease relapses — suggesting the eye may reveal hidden neurodegeneration.

Intensive Nurse-Led Supportive Care Tied to Better QOL

Higher nurse-led supportive care intensity is associated with a better quality of life and lower symptom burden in patients receiving palliative chemotherapy, a study reports.

Best Treatments for BD: Current Evidence, New Online Tool

A ‘living’ evidence review of bipolar disorder treatments has been transformed into a free, continuously updated online tool that helps clinicians and patients weigh efficacy, side effects, and individual preferences.

Add-On Citicoline May Improve Motor Function in PD

Citicoline added to dopaminergic therapy is safe and tied to higher odds of clinically meaningful improvement than placebo in motor function in Parkinson’s, a trial shows.

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Latest News

Bevacizumab is a cornerstone retina drug that has been used off-label for decades. Where the FDA-cleared branded version fits in may be a matter of cost and acceptance.

Healthcare workers are facing more violence and staff shortages, fueling hospital strikes as workers push for safer workplaces and enough staff to care for patients.

Thinning of specific retinal layers predicts cognitive worsening in patients with multiple sclerosis, even without disease relapses — suggesting the eye may reveal hidden neurodegeneration.

Higher nurse-led supportive care intensity is associated with a better quality of life and lower symptom burden in patients receiving palliative chemotherapy, a study reports.

A ‘living’ evidence review of bipolar disorder treatments has been transformed into a free, continuously updated online tool that helps clinicians and patients weigh efficacy, side effects, and individual preferences.

Citicoline added to dopaminergic therapy is safe and tied to higher odds of clinically meaningful improvement than placebo in motor function in Parkinson’s, a trial shows.

News All Time

Defining COPD Phenotypes With Advanced Imaging

Visual characteristics of lung disease are helping pulmonologists establish care plans and interventions.

Triple Therapy Reduces Antibiotic Use in Pediatric CF

A triple-combination therapy targeting the underlying defect in cystic fibrosis was associated with a dramatic reduction in antibiotic exposure among children and adolescents.

NHS Rehab Cuts Leaving Patients With ‘Avoidable Disability’

Recruitment freezes and lost rehab space are harming patient care, a CSP survey of 548 NHS physiotherapists finds.

ACARD Score Predicts Mortality in Status Epilepticus

A newly developed prognostic tool outperforms existing scoring systems in predicting short-term mortality risk following status epilepticus.

THC Safe, Effective for PTSD-Related Nightmares

Dronabinol, a medication containing THC, is linked to fewer nightmares at lower intensity compared to placebo in patients with post-traumatic stress disorder, new data show.

French Hospital Brings Phage Therapy Closer to Clinical Use

A first-in-world public authorization to manufacture GMP therapeutic phages could expand clinical trials, strengthen regulated access, and accelerate evidence-based treatment.

Self-Sampling Can Be Feasible for Respiratory Infections

A Swiss pilot study shows that self-sampling at home is feasible for detecting respiratory infections and supports creating a decentralised household-based cohort for pandemic preparedness.

Bipolar Disorder Linked to Higher Mortality in Older Adults

Bipolar disorder is associated with a 72% increased risk for mortality over 8 years in older adults compared with the general population, a new prospective study shows.

Prostate Surgery Leakage Improves Over 12 Months

About 1 in 5 patients develop urinary incontinence 3 months after thulium fiber laser enucleation of the prostate, with rates decreasing over 12 months.

Age and MRI Features Predict MS Odds After Initial Symptoms

Younger age at onset, multifocal symptoms, and specific MRI findings are associated with increased odds of multiple sclerosis diagnosis after a first demyelinating event.

Nirsevimab Linked to Lower Risk for IPD Hospitalizations

Nirsevimab immunization in children younger than 12 months is linked to a lower risk for hospitalization for invasive pneumococcal disease, a French nationwide analysis shows.

‘Big Beautiful’ Law Tests Rural Hospital Lifeline

A century-old hospital near Michigan’s southern border was one of the nation’s first to convert into a new emergency-focused model Congress created to save rural care.

Romanian Healthcare Workers End Strike Over Pay, Staffing

Romanian healthcare workers ended a nationwide strike on ⁠Friday as the country's caretaker government approved new hires in ⁠short-staffed state hospitals.

Swimming Linked to Reduced Disability in Low Back Pain

Swimming plus education is more effective than education alone in reducing disability in adults with chronic low back pain over 8 weeks, a trial shows.

Preterm Lung Disease: One Drug Testing May Miss Responders

Most children born premature with chronic lung disease have reversible airway obstruction, but bronchodilator responses vary widely, underscoring the need for individualized testing.

Vancomycin Prophylaxis Tied to Lower C difficile Recurrence

In children and young adults with cancer, oral vancomycin prophylaxis during broad-spectrum antibiotic therapy is associated with a lower risk for recurrent Clostridioides difficile infection.

Recommended News For You

Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.

Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor

Early, virtual palliative care feasible for advanced lung cancer

Coffee and tea linked to lower head and neck cancer risk

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

MGRS Relapse-Free Survival Better With Maintenance Therapy

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

Recommended Articles For You

Practical Applications in Hematology Across Clinical Settings 

Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control 

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target 

Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

2.

New drug combination shows good results in patients with HPV-negative head and neck cancer

3.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

4.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

5.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

1.

Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches

2.

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies 

3.

Progressive Insights in Hematology in the Digital Era

4.

Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations

5.

The importance of understanding normal serum osmolality

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

2.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

3.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot